Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized Withaferin-A for Steroid Refractory Acute Graft Versus Host Disease
NCT07708987Phase 2Recruiting
- Sponsor
- Tata Memorial Centre
- Start
- Sep 2023
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 2 trial of AshwaMAX in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Tata Memorial Centre. Started Sep 2023; status: recruiting.
02
Drugs
AshwaMAX
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT07708987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07708987.